MUCOSOLVAN TABLET 30 mg

מדינה: סינגפור

שפה: אנגלית

מקור: HSA (Health Sciences Authority)

מרכיב פעיל:

AMBROXOL HCl

זמין מ:

OPELLA HEALTHCARE SINGAPORE PTE. LTD.

קוד ATC:

R05CB06

כמות:

30 mg

טופס פרצבטיות:

TABLET

הרכב:

AMBROXOL HCl 30 mg

מסלול נתינה (של תרופות):

ORAL

סוג מרשם:

General Sale List

תוצרת:

Delpharm Reims

מצב אישור:

ACTIVE

תאריך אישור:

1989-05-02

עלון מידע

Revision Date: May 2022 (CCDS V1)
202001
Mucosolvan

30mg Tablets
ambroxol hydrochloride
Patient Information Leaflet
(a) What MUCOSOLVAN
tablets 30 mg contain
The active substance is
ambroxol:
Ambroxol hydrochloride.
Each tablet contains 30 mg
ambroxol hydrochloride.
The other ingredients are:
Lactose monohydrate
Maize starch, dried
Silica colloidal anhydrous
Magnesium stearate
Purified water
(b) What MUCOSOLVAN
tablets 30 mg are and what
they are used for
Mucosolvan is used in
conditions where there are a lot
of thick secretions or mucus in
your air passages.
Mucosolvan contains
ambroxol hydrochloride,
which helps to clear the chest
by thinning the mucus in your
air passage.
(c) What you need to know
before you take
MUCOSOLVAN tablets 30
mg
Do not take MUCOSOLVAN
tablets 30 mg

if you are allergic
(hypersensitive) to the
active substance ambroxol
hydrochloride or any of
the other ingredients of
this medicine (listed in
Section (a)).
Warnings and precautions
Talk to your doctor or
pharmacist before taking this
medicine.
There have been reports of
severe skin reactions
associated with the
administration of ambroxol
hydrochloride. If you develop
a skin rash (including lesions
of the mucous membranes
such as mouth, throat, nose,
eyes, genitals), stop using
MUCOSOLVAN tablets 30
mg and contact your doctor
immediately.
Patients with impaired kidney
or liver function
If you have impaired kidney
function or severe liver
disease, you must not take
MUCOSOLVAN tablets 30
mg except on medical advice.
With ambroxol, as with any
medicine which is broken
down in the liver and then
eliminated via the kidneys,
accumulation of the
breakdown products which are
formed in the liver can be
expected to occur in patients
with severely impaired kidney
function.
In some rare bronchial diseases
which are associated with
excessive accumulation of
secretions (such as primary
ciliary dyskinesia),
MUCOSOLVAN tablets 30
mg should only be used under
medical supervision because of
the risk that secretions may
accumulate.
Other medicines an

מאפייני מוצר

ambroxol hydrochloride
PATIENT INFORMATION LEAFLET
(A)
WHAT MUCOSOLVAN
TABLETS 30 MG CONTAIN
The active substance is ambroxol:
Ambroxol hydrochloride.
Each tablet contains 30 mg
ambroxol hydrochloride.
The other ingredients are:
Lactose monohydrate,
Maize starch, dried Silica
colloidal anhydrous
Magnesium stearate
Purified water.
WHAT MUCOSOLVAN
TABLETS 30 MG ARE AND WHAT
THEY ARE USED FOR
Mucosolvan is used in
conditions where there are a
lot of thick secretions or
mucus in your air passages.
Mucosolvan contains ambroxol
hydrochloride, which helps to
clear the chest by thinning the
mucus in your air passage.
WHAT YOU NEED TO KNOW BEFORE
YOU TAKE MUCOSOLVAN TABLETS
30 MG
DO NOT TAKE MUCOSOLVAN
TABLETS 30 MG
•
if you are allergic
(hypersensitive) to the active
substance ambroxol hydrochloride
or any of the other ingredients
of this medicine (listed in
Section (a)).
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist
before taking this medicine.
There have been reports of severe
skin reactions associated with the
administration of ambroxol
hydrochloride. If you develop a
skin rash (including lesions of the
mucous membranes such as mouth,
throat, nose, eyes, genitals),
stop using MUCOSOLVAN
tablets 30 mg and contact your
doctor immediately.
(B)
(C)
(D)
MucoT-001_RDSG (V2)
_Patients with impaired kidney or _
_liver function_
If you have impaired kidney function
or severe liver disease, you must not
take MUCOSOLVAN tablets 30 mg
except on medical advice. With
ambroxol, as with any medicine
which is broken down in the liver
and then eliminated via the kidneys,
accumulation of the breakdown
products which are formed in the
liver can be expected to occur in
patients with severely impaired
kidney function.
In some rare bronchial diseases
which are associated with excessive
accumulation of secretions (such as
primary ciliary dyskinesia),
MUCOSOLVAN tablets 30 mg
should only be used under medical
supervision because of the risk that
secretions may accumulate.
OTHER MEDICINES AND
MUCOSOLVAN TABLETS 30 MG
Tell your d